MSB 0.00% $1.02 mesoblast limited

Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-274

  1. 334 Posts.
    lightbulb Created with Sketch. 368
    Agree that Covid would most definitely wreaked havoc with the work schedule of the agency.

    “The FDA is back on track, and the pace of approval is rapidly gaining steam. Their messaging is that they want to approve. Look at the gene therapy space by way of example.

    You are not wrong to be cautious, but I expect the current FDA to surprise in how quickly they progress this.” - thanks again @kingfedex
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.02
Change
0.000(0.00%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.02 $1.04 $1.02 $1.415M 1.379M

Buyers (Bids)

No. Vol. Price($)
19 166665 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 47632 28
View Market Depth
Last trade - 12.47pm 01/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.